tiprankstipranks
Quest Diagnostics (CH:QDI)
:QDI
Switzerland Market
QDI
Quest Diagnostics
RESEARCH TOOLSreports

Quest Diagnostics (QDI) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

QDI Analyst Ratings

Moderate Buy
11Ratings
Moderate Buy
7 Buy
4 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Quest
Diagnostics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

QDI Stock 12 Month Forecast

Average Price Target

―
Based on 11 Wall Street analysts offering 12 month price targets for Quest Diagnostics in the last 3 months. The average price target is CHF201.92 with a high forecast of CHF211.75 and a low forecast of CHF185.38. The average price target represents a ― change from the last price of ―.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"184":"CHF184","191":"CHF191","198":"CHF198","205":"CHF205","212":"CHF212"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":211.75216405,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF211.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":201.92366737899997,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF201.92</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":185.38302664,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF185.38</span>\n  </div></div>","useHTML":true}}],"tickPositions":[184,191,198,205,212],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,186.244,188.20616646538463,190.16833293076922,192.13049939615385,194.09266586153845,196.05483232692308,198.0169987923077,199.9791652576923,201.94133172307693,203.90349818846153,205.86566465384615,207.82783111923078,209.78999758461538,{"y":211.75216405,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,186.244,187.45012825992308,188.65625651984615,189.86238477976923,191.0685130396923,192.27464129961538,193.48076955953846,194.6868978194615,195.89302607938458,197.09915433930766,198.30528259923074,199.5114108591538,200.7175391190769,{"y":201.92366737899997,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,186.244,186.17777128,186.11154256,186.04531384,185.97908512,185.9128564,185.84662768,185.78039895999999,185.71417024,185.64794152,185.5817128,185.51548408,185.44925536,{"y":185.38302664,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":186.244,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.244,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.244,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.244,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.244,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.244,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.244,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.244,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.244,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.244,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.244,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.244,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.244,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF211.75Average Price TargetCHF201.92Lowest Price TargetCHF185.38
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CH:QDI
Erin Wright
Morgan Stanley
Morgan Stanley
CHF207.76
Buy
―
Reiterated
08/19/26
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX) and Irhythm Technologies (NASDAQ: IRTC)
Truist Financial Analyst forecast on CH:QDI
David S Macdonald
Truist Financial
Truist Financial
CHF199.77
Hold
―
Reiterated
07/28/26
Truist Financial Sticks to Their Hold Rating for Quest Diagnostics (DGX)
Mizuho Securities Analyst forecast on CH:QDI
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF207.76
Buy
―
Reiterated
07/28/26
Analysts Offer Insights on Healthcare Companies: Biogen (NASDAQ: BIIB), Quest Diagnostics (NYSE: DGX) and Otsuka Holdings Co (Other OTC: OTSKF)
Argus Research Analyst forecast on CH:QDI
David Toung
Argus Research
Argus Research
CHF207.76
Buy
―
Reiterated
07/28/26
Argus Research Keeps Their Buy Rating on Quest Diagnostics (DGX)
J.P. Morgan Analyst forecast on CH:QDI
Lisa Gill
J.P. Morgan
J.P. Morgan
CHF175.79→CHF199.77
Hold
―
Assigned
07/28/26
Quest Diagnostics price target raised to $250 from $220 at JPMorganQuest Diagnostics price target raised to $250 from $220 at JPMorgan
Robert W. Baird Analyst forecast on CH:QDI
Eric Coldwell
Robert W. Baird
Robert W. Baird
CHF188.58→CHF203.76
Hold
―
Reiterated
07/24/26
Quest Diagnostics price target raised to $255 from $236 at BairdQuest Diagnostics price target raised to $255 from $236 at Baird
Barclays Analyst forecast on CH:QDI
Luke Sergott
Barclays
Barclays
CHF183.78→CHF199.77
Buy
―
Reiterated
07/24/26
Quest Diagnostics price target raised to $250 from $230 at BarclaysQuest Diagnostics price target raised to $250 from $230 at Barclays
Bank of America Securities Analyst forecast on CH:QDI
Michael Ryskin
Bank of America Securities
Bank of America Securities
CHF211.75
Buy
―
Reiterated
07/24/26
Quest Diagnostics price target raised to $265 from $245 at BofAQuest Diagnostics price target raised to $265 from $245 at BofA
UBS Analyst forecast on CH:QDI
Kevin Caliendo
UBS
UBS
CHF175.79→CHF185.38
Hold
―
Reiterated
07/24/26
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (NASDAQ: HRMY) and Quest Diagnostics (NYSE: DGX)
Jefferies Analyst forecast on CH:QDI
Tycho Peterson
Jefferies
Jefferies
CHF179.79→CHF195.77
Buy
―
Reiterated
07/23/26
Quest Diagnostics price target raised to $245 from $225 at JefferiesQuest Diagnostics price target raised to $245 from $225 at Jefferies
William Blair Analyst forecast on CH:QDI
Jared Haase
William Blair
William Blair
―
Buy
―
Reiterated
07/23/26
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX) and MindWalk Holdings (NASDAQ: HYFT)
Evercore ISI Analyst forecast on CH:QDI
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF167.8
Hold
―
Reiterated
04/20/26
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX), Centessa Pharmaceuticals (NASDAQ: CNTA) and Perspective Therapeutics (NYSE MKT: CATX)
Citi Analyst forecast on CH:QDI
Patrick B Donnelly
Citi
Citi
CHF151.82→CHF171.8
Hold
―
Reiterated
02/11/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Biogen (NASDAQ: BIIB) and Quest Diagnostics (NYSE: DGX)
Piper Sandler Analyst forecast on CH:QDI
David Westenberg
Piper Sandler
Piper Sandler
CHF151.82→CHF159.81
Hold
―
Reiterated
10/27/25
Quest Diagnostics price target raised to $200 from $190 at Piper SandlerQuest Diagnostics price target raised to $200 from $190 at Piper Sandler
Leerink Partners Analyst forecast on CH:QDI
Michael Cherny
Leerink Partners
Leerink Partners
CHF162.21→CHF167.8
Buy
―
Reiterated
10/22/25
Quest Diagnostics price target raised to $210 from $203 at LeerinkQuest Diagnostics price target raised to $210 from $203 at Leerink
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on CH:QDI
Erin Wright
Morgan Stanley
Morgan Stanley
CHF207.76
Buy
―
Reiterated
08/19/26
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX) and Irhythm Technologies (NASDAQ: IRTC)
Truist Financial Analyst forecast on CH:QDI
David S Macdonald
Truist Financial
Truist Financial
CHF199.77
Hold
―
Reiterated
07/28/26
Truist Financial Sticks to Their Hold Rating for Quest Diagnostics (DGX)
Mizuho Securities Analyst forecast on CH:QDI
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF207.76
Buy
―
Reiterated
07/28/26
Analysts Offer Insights on Healthcare Companies: Biogen (NASDAQ: BIIB), Quest Diagnostics (NYSE: DGX) and Otsuka Holdings Co (Other OTC: OTSKF)
Argus Research Analyst forecast on CH:QDI
David Toung
Argus Research
Argus Research
CHF207.76
Buy
―
Reiterated
07/28/26
Argus Research Keeps Their Buy Rating on Quest Diagnostics (DGX)
J.P. Morgan Analyst forecast on CH:QDI
Lisa Gill
J.P. Morgan
J.P. Morgan
CHF175.79→CHF199.77
Hold
―
Assigned
07/28/26
Quest Diagnostics price target raised to $250 from $220 at JPMorganQuest Diagnostics price target raised to $250 from $220 at JPMorgan
Robert W. Baird Analyst forecast on CH:QDI
Eric Coldwell
Robert W. Baird
Robert W. Baird
CHF188.58→CHF203.76
Hold
―
Reiterated
07/24/26
Quest Diagnostics price target raised to $255 from $236 at BairdQuest Diagnostics price target raised to $255 from $236 at Baird
Barclays Analyst forecast on CH:QDI
Luke Sergott
Barclays
Barclays
CHF183.78→CHF199.77
Buy
―
Reiterated
07/24/26
Quest Diagnostics price target raised to $250 from $230 at BarclaysQuest Diagnostics price target raised to $250 from $230 at Barclays
Bank of America Securities Analyst forecast on CH:QDI
Michael Ryskin
Bank of America Securities
Bank of America Securities
CHF211.75
Buy
―
Reiterated
07/24/26
Quest Diagnostics price target raised to $265 from $245 at BofAQuest Diagnostics price target raised to $265 from $245 at BofA
UBS Analyst forecast on CH:QDI
Kevin Caliendo
UBS
UBS
CHF175.79→CHF185.38
Hold
―
Reiterated
07/24/26
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (NASDAQ: HRMY) and Quest Diagnostics (NYSE: DGX)
Jefferies Analyst forecast on CH:QDI
Tycho Peterson
Jefferies
Jefferies
CHF179.79→CHF195.77
Buy
―
Reiterated
07/23/26
Quest Diagnostics price target raised to $245 from $225 at JefferiesQuest Diagnostics price target raised to $245 from $225 at Jefferies
William Blair Analyst forecast on CH:QDI
Jared Haase
William Blair
William Blair
―
Buy
―
Reiterated
07/23/26
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX) and MindWalk Holdings (NASDAQ: HYFT)
Evercore ISI Analyst forecast on CH:QDI
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
CHF167.8
Hold
―
Reiterated
04/20/26
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX), Centessa Pharmaceuticals (NASDAQ: CNTA) and Perspective Therapeutics (NYSE MKT: CATX)
Citi Analyst forecast on CH:QDI
Patrick B Donnelly
Citi
Citi
CHF151.82→CHF171.8
Hold
―
Reiterated
02/11/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Biogen (NASDAQ: BIIB) and Quest Diagnostics (NYSE: DGX)
Piper Sandler Analyst forecast on CH:QDI
David Westenberg
Piper Sandler
Piper Sandler
CHF151.82→CHF159.81
Hold
―
Reiterated
10/27/25
Quest Diagnostics price target raised to $200 from $190 at Piper SandlerQuest Diagnostics price target raised to $200 from $190 at Piper Sandler
Leerink Partners Analyst forecast on CH:QDI
Michael Cherny
Leerink Partners
Leerink Partners
CHF162.21→CHF167.8
Buy
―
Reiterated
10/22/25
Quest Diagnostics price target raised to $210 from $203 at LeerinkQuest Diagnostics price target raised to $210 from $203 at Leerink
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ODTXOdyssey Therapeutics, Inc.
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Quest Diagnostics

3 Months
Michael RyskinBank of America Securities
Success Rate
11/12 ratings generated profit
92%
Average Return
+6.32%
Copying Michael Ryskin's trades and holding each position for 3 Months would result in 91.67% of your transactions generating a profit, with an average return of +6.32% per trade.
1 Year
Michael ChernyLeerink Partners
Success Rate
8/8 ratings generated profit
100%
Average Return
+25.16%
Copying Michael Cherny's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.16% per trade.
2 Years
Michael RyskinBank of America Securities
Success Rate
12/12 ratings generated profit
100%
Average Return
+41.17%
Copying Michael Ryskin's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +41.17% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QDI Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
11
5
7
12
13
Hold
10
6
6
7
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
21
11
13
19
19
In the current month, QDI has received 13 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. QDI average Analyst price target in the past 3 months is 201.92.
Each month's total comprises the sum of three months' worth of ratings.

QDI Financial Forecast

QDI Earnings Forecast

Next quarter’s earnings estimate for QDI is CHF2.34 with a range of CHF2.30 to CHF2.40. The previous quarter’s EPS was CHF2.54. QDI beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year QDI has Outperformed its overall industry.
Next quarter’s earnings estimate for QDI is CHF2.34 with a range of CHF2.30 to CHF2.40. The previous quarter’s EPS was CHF2.54. QDI beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year QDI has Outperformed its overall industry.

QDI Sales Forecast

Next quarter’s sales forecast for QDI is CHF2.48B with a range of CHF2.41B to CHF2.52B. The previous quarter’s sales results were CHF2.48B. QDI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year QDI has Outperformed its overall industry.
Next quarter’s sales forecast for QDI is CHF2.48B with a range of CHF2.41B to CHF2.52B. The previous quarter’s sales results were CHF2.48B. QDI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year QDI has Outperformed its overall industry.

QDI Stock Forecast FAQ

What is CH:QDI’s average 12-month price target, according to analysts?
Based on analyst ratings, Quest Diagnostics’s 12-month average price target is 201.92.
    What is CH:QDI’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:QDI, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Quest Diagnostics a Buy, Sell or Hold?
        Quest Diagnostics has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 4 hold ratings and 0 sell ratings.
          What is Quest Diagnostics’s share price target?
          The average share price target for Quest Diagnostics is 201.92. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF211.75 ,and the lowest forecast is CHF185.38. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Quest Diagnostics?
            Quest Diagnostics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
              How can I buy shares of Quest Diagnostics?
              To buy shares of CH:QDI, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.